✦ LIBER ✦

7027 Interim results of a phase II trial of oxaliplatin and pemetrexed as 2nd/3rd line therapy in castration resistant prostate cancer (CRPC)

✍ Scribed by Dorff, T.B.; Groshen, S.; Tsao-Wei, D.D.; Goldkorn, A.; Korn, C.; Quinn, D.I.; Pinski, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P118 Preliminary results of HOPLITE tria

✍ Caffo, O.; Lo Re, G.; Sava, T.; Buti, S.; Sacco, C.; Basso, U.; Zustovich, F.; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

7036 Phase II study with pharmacodynamic

✍ Fontana, A.; Galli, L.; Derosa, L.; Minuti, G.; D'Arcangelo, M.; Bursi, S.; Land 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

2LB Late Breaking A phase II study of ab

✍ C. Ryan; A. Harzstark; L. Fong; A. Lin; C. Kilian; A. Molina; E.J. Small 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Re: Serum Androgens as Prognostic Biomar

✍ Taneja, Samir S. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 41 KB

649 POSTER Erlotinib as single agent in

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

7049 Early results of a phase II trial o

✍ Blesa, J. Gasent; Candel, V. Alberola; Vidal, O. Juan; Fuentes, P. Cerezuela; Ma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB